Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
28.48
-0.02 (-0.07%)
Nov 28, 2025, 4:00 PM EST - Market closed
Pelthos Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Pelthos Therapeutics stock have an average target of 57, which predicts a 100.14% increase from the current stock price of 28.48.
Price Target: $57 (+100.14%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pelthos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|
| Strong Buy | 0 | 0 | 1 |
| Buy | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth Capital | Roth Capital | Strong Buy Initiates $57 | Strong Buy | Initiates | $57 | +100.14% | Nov 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $50 → $57 | Buy | Reiterates | $50 → $57 | +100.14% | Nov 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +75.56% | Sep 2, 2025 |
Financial Forecast
Revenue This Year
8.88M
Revenue Next Year
32.21M
from 8.88M
Increased by 262.88%
EPS This Year
-2.60
from -14.27
EPS Next Year
-1.58
from -2.60
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.4M | 38.4M | |||
| Avg | 8.9M | 32.2M | |||
| Low | 5.5M | 26.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 332.9% | |||
| Avg | - | 262.9% | |||
| Low | - | 193.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.68 | -0.74 | |||
| Avg | -2.60 | -1.58 | |||
| Low | -2.50 | -2.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.